126 related articles for article (PubMed ID: 23258075)
1. Mononuclear leukocyte apoptosis and inflammatory markers in patients with chronic kidney disease.
Dounousi E; Koliousi E; Papagianni A; Ioannou K; Zikou X; Katopodis K; Kelesidis A; Tsakiris D; Siamopoulos KC
Am J Nephrol; 2012; 36(6):531-6. PubMed ID: 23258075
[TBL] [Abstract][Full Text] [Related]
2. Not all inflammatory markers are linked to kidney function: results from a population-based study.
Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
[TBL] [Abstract][Full Text] [Related]
3. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
[TBL] [Abstract][Full Text] [Related]
4. Intraindividual interleukin-6 variations on the cardiovascular prognosis of patients with chronic renal disease.
Goicoechea M; Quiroga B; García de Vinuesa S; Verdalles U; Reque J; Panizo N; Arroyo D; Santos A; Macías N; Luño J
Ren Fail; 2012; 34(8):1002-9. PubMed ID: 22746155
[TBL] [Abstract][Full Text] [Related]
5. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
Liabeuf S; Barreto DV; Barreto FC; Chasseraud M; Brazier M; Choukroun G; Kamel S; Massy ZA
Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
[TBL] [Abstract][Full Text] [Related]
6. Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients.
Spoto B; Leonardis D; Parlongo RM; Pizzini P; Pisano A; Cutrupi S; Testa A; Tripepi G; Zoccali C; Mallamaci F
Nutr Metab Cardiovasc Dis; 2012 Nov; 22(11):981-8. PubMed ID: 21906921
[TBL] [Abstract][Full Text] [Related]
7. The sFas/sFasL ratio as a novel marker of inflammation in children with chronic kidney disease.
Musiał K; Zwolińska D
Clin Chim Acta; 2012 Dec; 414():7-11. PubMed ID: 22898262
[TBL] [Abstract][Full Text] [Related]
8. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease.
Okyay GU; Inal S; Oneç K; Er RE; Paşaoğlu O; Paşaoğlu H; Derici U; Erten Y
Ren Fail; 2013; 35(1):29-36. PubMed ID: 23113674
[TBL] [Abstract][Full Text] [Related]
10. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease.
Lee BT; Ahmed FA; Hamm LL; Teran FJ; Chen CS; Liu Y; Shah K; Rifai N; Batuman V; Simon EE; He J; Chen J
BMC Nephrol; 2015 May; 16():77. PubMed ID: 26025192
[TBL] [Abstract][Full Text] [Related]
11. Increased apoptosis of peripheral blood mononuclear cells in patients with perennial allergic asthma/rhinitis: relation to serum markers of apoptosis.
Grzegorczyk J; Kowalski ML; Pilat A; Iwaszkiewicz J
Mediators Inflamm; 2002 Aug; 11(4):225-33. PubMed ID: 12396474
[TBL] [Abstract][Full Text] [Related]
12. Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation.
Palermo A; Mulè G; Vadalà A; Vaccaro F; Guarneri M; Arsena R; Briolotta C; Cerasola G; Cottone S
Nephrology (Carlton); 2008 Apr; 13(2):164-70. PubMed ID: 18275506
[TBL] [Abstract][Full Text] [Related]
13. Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status.
Norata GD; Baragetti I; Raselli S; Stucchi A; Garlaschelli K; Vettoretti S; Piloni G; Buccianti G; Catapano AL
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):56-63. PubMed ID: 19359150
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD.
Smith ER; Ford ML; Tomlinson LA; Rajkumar C; McMahon LP; Holt SG
Nephrol Dial Transplant; 2012 May; 27(5):1957-66. PubMed ID: 22105144
[TBL] [Abstract][Full Text] [Related]
15. Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease.
Hébert MJ; Masse M; Vigneault N; Sirois I; Troyanov S; Madore F
Am J Kidney Dis; 2001 Dec; 38(6):1271-6. PubMed ID: 11728960
[TBL] [Abstract][Full Text] [Related]
16. Fas expression in nephrectomized, non-cancerous specimens predicts post-nephrectomy chronic kidney disease progression in patients with renal and upper urinary tract malignancies.
Sejima T; Iwamoto H; Morizane S; Hinata N; Yao A; Isoyama T; Saito M; Amisaki T; Takenaka A
Urol Oncol; 2013 Nov; 31(8):1812-9. PubMed ID: 22591748
[TBL] [Abstract][Full Text] [Related]
17. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
[TBL] [Abstract][Full Text] [Related]
18. Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients.
Gonçalves S; Pecoits-Filho R; Perreto S; Barberato SH; Stinghen AE; Lima EG; Fuerbringer R; Sauthier SM; Riella MC
Nephrol Dial Transplant; 2006 Oct; 21(10):2788-94. PubMed ID: 16861246
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and Progression of CKD: The CRIC Study.
Amdur RL; Feldman HI; Gupta J; Yang W; Kanetsky P; Shlipak M; Rahman M; Lash JP; Townsend RR; Ojo A; Roy-Chaudhury A; Go AS; Joffe M; He J; Balakrishnan VS; Kimmel PL; Kusek JW; Raj DS;
Clin J Am Soc Nephrol; 2016 Sep; 11(9):1546-1556. PubMed ID: 27340285
[TBL] [Abstract][Full Text] [Related]
20. The effects of fish oil supplementation on markers of inflammation in chronic kidney disease patients.
Deike E; Bowden RG; Moreillon JJ; Griggs JO; Wilson RL; Cooke M; Shelmadine BD; Beaujean AA
J Ren Nutr; 2012 Nov; 22(6):572-7. PubMed ID: 22285316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
